RVPH
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Jul 29 closing price
Capitalization
31.95M
19 days until earnings call
VTGN
Price
$3.07
Change
+$0.01 (+0.33%)
Updated
Jul 30, 10:34 AM (EDT)
Capitalization
89.22M
Interact to see
Advertisement

RVPH vs VTGN

Header iconRVPH vs VTGN Comparison
Open Charts RVPH vs VTGNBanner chart's image
Reviva Pharmaceuticals Holdings
Price$0.49
Change-$0.00 (-0.00%)
Volume$147.79K
Capitalization31.95M
VistaGen Therapeutics
Price$3.07
Change+$0.01 (+0.33%)
Volume$450
Capitalization89.22M
RVPH vs VTGN Comparison Chart in %
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVPH vs. VTGN commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a StrongBuy and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (RVPH: $0.47 vs. VTGN: $3.06)
Brand notoriety: RVPH and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 151% vs. VTGN: 270%
Market capitalization -- RVPH: $31.95M vs. VTGN: $89.22M
RVPH [@Biotechnology] is valued at $31.95M. VTGN’s [@Biotechnology] market capitalization is $89.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both RVPH and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • RVPH’s TA Score: 4 bullish, 4 bearish.
  • VTGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than RVPH.

Price Growth

RVPH (@Biotechnology) experienced а +14.39% price change this week, while VTGN (@Biotechnology) price change was +20.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +15.03%, and the average quarterly price growth was +41.55%.

Reported Earning Dates

RVPH is expected to report earnings on Nov 17, 2025.

VTGN is expected to report earnings on Jun 17, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($89.2M) has a higher market cap than RVPH($31.9M). VTGN YTD gains are higher at: 3.729 vs. RVPH (-74.044). RVPH has higher annual earnings (EBITDA): -28.87M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. RVPH (5.29M). RVPH has less debt than VTGN: RVPH (224K) vs VTGN (1.71M). VTGN has higher revenues than RVPH: VTGN (698K) vs RVPH (0).
RVPHVTGNRVPH / VTGN
Capitalization31.9M89.2M36%
EBITDA-28.87M-52.22M55%
Gain YTD-74.0443.729-1,986%
P/E RatioN/AN/A-
Revenue0698K-
Total Cash5.29M88.6M6%
Total Debt224K1.71M13%
FUNDAMENTALS RATINGS
RVPH vs VTGN: Fundamental Ratings
RVPH
VTGN
OUTLOOK RATING
1..100
134
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
10100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for RVPH (92) in the null industry. This means that VTGN’s stock grew somewhat faster than RVPH’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that VTGN’s stock grew similarly to RVPH’s over the last 12 months.

VTGN's SMR Rating (96) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that VTGN’s stock grew similarly to RVPH’s over the last 12 months.

VTGN's Price Growth Rating (38) in the Biotechnology industry is in the same range as RVPH (64) in the null industry. This means that VTGN’s stock grew similarly to RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (10) in the null industry is significantly better than the same rating for VTGN (100) in the Biotechnology industry. This means that RVPH’s stock grew significantly faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVPHVTGN
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FET20.680.05
+0.24%
Forum Energy Technologies
DOCS59.70-1.30
-2.13%
Doximity
NRDS10.62-0.31
-2.84%
NerdWallet
AON354.03-15.13
-4.10%
Aon plc
MSW2.38-0.49
-16.94%
Ming Shing Group Holdings Ltd

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-4.12%
ALT - RVPH
50%
Loosely correlated
-4.96%
INDP - RVPH
30%
Poorly correlated
-8.00%
GYRE - RVPH
30%
Poorly correlated
-6.27%
INM - RVPH
26%
Poorly correlated
+1.14%
ARCT - RVPH
25%
Poorly correlated
-9.18%
More